Brio Consultants’s Schwab Fundamental Emerging Markets Large Company Index ETF FNDE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.06M Buy
50,251
+7,341
+17% +$283K 0.25% 55
2025
Q4
$1.55M Buy
42,910
+14,189
+49% +$518K 0.2% 61
2025
Q3
$1.04M Sell
28,721
-1,019
-3% -$35.1K 0.14% 65
2025
Q2
$982K Buy
29,740
+8,610
+41% +$268K 0.14% 68
2025
Q1
$651K Buy
21,130
+1,243
+6% +$37.6K 0.1% 70
2024
Q4
$578K Buy
19,887
+4,666
+31% +$145K 0.09% 74
2024
Q3
$491K Sell
15,221
-4,442
-23% -$133K 0.08% 79
2024
Q2
$581K Buy
19,663
+5,053
+35% +$147K 0.1% 68
2024
Q1
$406K Buy
14,610
+839
+6% +$22.6K 0.07% 76
2023
Q4
$374K Buy
+13,771
New +$362K 0.07% 76
2022
Q4
Sell
-8,965
Closed -$209K 91
2022
Q3
$209K Buy
+8,965
New +$229K 0.04% 92

Other funds holding FNDE

Brio Consultants's FNDE Position: Q1 2026 in Review

Brio Consultants increased its Schwab Fundamental Emerging Markets Large Company Index ETF (FNDE) stake by 17% in Q1 2026, buying an estimated $283K and bringing the position to 50,251 shares worth $2.06M. The position accounts for 0.25% of the portfolio, ranked #55.

Brio Consultants first reported a position in FNDE in Q3 2022 and has held it in 11 quarters since. 471 funds tracked by Wall St. Rank hold FNDE as of Q1 2026.

  • Brio Consultants held 50,251 shares of Schwab Fundamental Emerging Markets Large Company Index ETF worth $2.06M as of Q1 2026.
  • Brio Consultants bought 7,341 Schwab Fundamental Emerging Markets Large Company Index ETF shares in Q1 2026, an estimated $283K.
  • Schwab Fundamental Emerging Markets Large Company Index ETF made up 0.25% of Brio Consultants's portfolio in Q1 2026, its #55 holding.
  • Brio Consultants first reported a position in Schwab Fundamental Emerging Markets Large Company Index ETF in Q3 2022 and has held it in 11 quarters since.
  • 471 funds tracked by Wall St. Rank held Schwab Fundamental Emerging Markets Large Company Index ETF as of Q1 2026.

Based on Brio Consultants's 13F filing for Q1 2026, filed 6 May 2026.